Rupintrivir (AG-7088) is a novel, selective and irreversible rhinovirus 3C protease inhibitor potentially for the treatment of human rhinovirus-HRV infection. Rupintrivirvr inhibits the replication of a panel of 48 different HRV serotypes in H1-HeLA and MRC-5 cell protection assays with a mean EC50 of 0.023 μM.

纯度：≥98%

CAS：223537-30-2